The early addition of a second anti-MRSA antibiotic to vancomycin may reduce mortality in severe cases of influenza-MRSA co-infection in children.
There is a correlation for documented penicillin allergy with increased risk of MRSA and C diff, which is mediated by increased use of β-lactam alternative antibiotics.
Increasing costs associated with hospitalizations involving MSSA infection are expected to surpass national costs for hospitalizations associated with MRSA.
Researchers assessed the ability of environmental screening as a proxy for patient colonization to reduce transmission of MRSA and VRE in nursing facilities.
FIRVANQ is commercially available in 25 and 50 mg/mL strengths in convenient 150 mL and 300 mL sizes.
In an attempt to determine if the presence of S aureus could be used as a marker for more severe disease, investigators assessed the relationship between S aureus-positive bronchiectasis infection and pulmonary function, frequency of exacerbations, and hospital admissions.
Further studies are warranted to assess the efficacy and safety of fosfomycin plus imipenem against methicillin-resistant Staphylococcus aureus complicated infections.
MRSA nares screening can be a stewardship tool to streamline empiric antibiotic therapy among those not nares colonized with MRSA.
A new expert guidance concerning contact precautions for multidrug resistant bacteria has been released.
The prevalence of methicillin-resistant Staphylococcus aureus colonization did not decline after implementation of state-legislated active surveillance among critically ill adults.
Mortality rates associated with infective endocarditis range from 16% to 25%, with the highest rates observed among patients with nosocomial healthcare-associated infective endocarditis.
Vancomycin administered via continuous infusion was found to achieve the recommended VAN trough of 15-20mg/L faster and with less risk of adverse events compared to administration via intermittent infusion.
Many of the recommendations by sports organizations are more stringent than ordinary infection control practices for similar conditions.
Study results can be used to support an antimicrobial stewardship policy discouraging empiric coverage for MRSA infections in a population of MSSA carriers.
Increase use of evidence-based care processes decreased mortality associated with S aureus bacteremia in VHA hospitals.
Adding trimethoprim-sulfamethoxazole to cephalexin treatment for cellulitis does not benefit outcomes compared to cephalexin alone.
Theravance Biopharma announced positive results from 3 studies on Vibativ (telavancin), a lipoglycopeptide antibiotic.
A carbapenem with vancomycin is the least resistant initial antibiotic combination to use in patients with an infected diabetic foot ulcer.
Disinfecting surfaces is key to preventing nosocomial transmission of pathogens such as C difficile, MRSA, and vancomycin-resistant enterococci.
Intravenous daptomycin may be effective and well-tolerated in children, possibly providing an alternative treatment against methicillin-resistant Staphylococcus aureus (MRSA) skin infections in this patient population.
Study finds that patients were 10% to 30% less likely to acquire a multidrug-resistant organism or C difficile if enhanced disinfection strategies were used in hospitals.
Researchers found that, over 8 years, MRSA health care-associated infection rates significantly declined.
A recent study found that hog workers in the North Carolina are developing skin infections from multidrug-resistant Staphylococcus aureus.
Clindamycin or TMP-SMX following I&D was more effective at curing Staphylococcus aureus infection in children and adults compared with placebo.
The use of prophages can reduce invasiveness in S aureus infections of diabetic foot ulcers that limit intracellular growth.
S aureus colonization was associated with particular SLE phenotypes.
Community-acquired Staphylococcus aureus bacteremia risk rose along with the dosage.
During study period, decrease noted in S. aureus susceptibility to clindamycin.
Risk up seven-fold among patients with type 1 diabetes, almost three-fold for those with type 2.
Higher clinical cure rate compared with placebo in setting in which MRSA was prevalent.
Sign Up for Free e-newsletters
Infectious Disease Advisor Articles
- Clinicians Warn That Zika Virus May Still Be an Area of Concern for Travelers
- Inappropriate Prescribing of Antibiotics High in Urgent Care Centers
- Fixed-Dose Bictegravir Regimen: A Safe Alternative in Adults With HIV-1
- Point-Counterpoint: Should We Implement Needle Exchange Programs for the Prevention of Hepatitis C Virus?
- FDA: Vibrio parahaemolyticus Illnesses Tied to Fresh Crab Meat From Venezuela
- Universal Purchase Programs in the United States May Not Effectively Increase Vaccination Rates
- Tick-Caused Meat Allergy on the Rise in the United States
- Prognostic Biomarkers to Guide Antibiotic Therapy in Critically Ill Patients
- Sofosbuvir/Velpatavir Effective for HCV-Infected Liver Transplant Recipients
- Should Metronidazole Be Recommended for Mild Clostridium difficile Infections?
- Same-Day ART Initiation in HIV+ Pregnant Women Does Not Worsen Outcomes
- Novel Nanodiagnostic Panel May Reduce Empiric Antifungal Use in High-Risk Candidemia
- Antimicrobial Lock Solutions Are Cost-Effective for Preventing Central Line-Associated Bloodstream Infections
- Predictors of Influenza Vaccine Acceptance in Inflammatory Rheumatic Diseases
- Pegylated Interferon, Ribavirin May Improve LV Diastolic Dysfunction in Chronic Hepatitis C